Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $0 - $0
0 New
0 $0
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $0 - $0
0 New
0 $0
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $0 - $0
0 New
0 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Natixis Portfolio

Follow Natixis and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.